Ikonisys (FRA:9W8) Accounts Payable: €1.53 Mil (As of Jun. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:9W8 Ikonisys SA FRA:9W8
65 GF Score
Price €1.37
GF Value €3.68
! 7 Warning Signs
View Full Analysis

What is Ikonisys Accounts Payable?

Ikonisys FRA:9W8 +3.01% 65 Accounts Payable is €1.53 Mil as of Jun. 2025. GuruFocus rates FRA:9W8 with a GF Score™ of 65/100 and a GF Value™ of €3.68. The stock has 7 warning signs investors should review.

Ikonisys's Accounts Payable for the quarter that ended in Jun. 2025 was €1.53 Mil.

Ikonisys's quarterly Accounts Payable increased from Jun. 2024 (€1.51 Mil) to Dec. 2024 (€1.74 Mil) but then declined from Dec. 2024 (€1.74 Mil) to Jun. 2025 (€1.53 Mil).

Ikonisys's annual Accounts Payable increased from Dec. 2022 (€1.08 Mil) to Dec. 2023 (€1.29 Mil) and increased from Dec. 2023 (€1.29 Mil) to Dec. 2024 (€1.74 Mil).

Ikonisys Accounts Payable Historical Data

* Premium members only.

The historical data trend for Ikonisys's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Ikonisys Accounts Payable Chart

Ikonisys Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Accounts Payable
Get a 7-Day Free Trial 0.98 1.08 1.29 1.74 0.00

Ikonisys Semi-Annual Data
Dec19 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Accounts Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.29 1.51 1.74 1.53 0.00
FRA:9W8
65GF Score
Ikonisys SA FRA:9W8
Accounts Payable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Ikonisys Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.

Frequently Asked Questions Learn more about Accounts Payable →
What does a Accounts Payable of €1.53 Mil mean?
Ikonisys (FRA:9W8) has a Accounts Payable of €1.53 Mil as of Jun. 2025. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on Ikonisys and its competitors.
Is Ikonisys' Accounts Payable too high?
Ikonisys' current Accounts Payable is €1.53 Mil. Overall, Ikonisys has a GF Score™ of 65/100, reflecting its overall financial health beyond just this single metric.
How does Ikonisys' Accounts Payable compare to ABT and SYK?
Ikonisys' Accounts Payable of €1.53 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Accounts Payable for a Medical Devices & Instruments company?
A good Accounts Payable depends on the Medical Devices & Instruments industry context. However, Accounts Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Accounts Payable mean?
A high Accounts Payable can signal that a stock is expensive relative to its fundamentals. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on Ikonisys and its competitors. Ikonisys's current Accounts Payable is €1.53 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ikonisys stock overvalued right now?
Ikonisys (FRA:9W8) has a current Accounts Payable of €1.53 Mil. The stock's GF Value™ is €3.68, compared to a current price of €1.37 — trading 62.8% below its estimated fair value. The current Accounts Payable is €1.53 Mil. Ikonisys' overall GF Score™ is 65/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Accounts Payable calculated?
Accounts Payable is calculated from a company's financial statements. For Ikonisys (FRA:9W8), the current Accounts Payable is €1.53 Mil as of Jun. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Ikonisys (FRA:9W8) Overvalued in 2026?

Based on GuruFocus' analysis, Ikonisys stock appears to be undervalued. The current stock price of €1.37 is trading 62.8% below its estimated GF Value™ of €3.68.

Key valuation signals for FRA:9W8:

  • Accounts Payable: €1.53 Mil
  • GF Value™: €3.68 vs. price of €1.37 (62.8% below fair value)
  • GF Score™: 65/100 with 7 warning signs

No single metric tells the full story. See the FRA:9W8 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Ikonisys Business Description

Other Exchanges ALIKO:France
Address 62 Rue de Caumartin, Paris, FRA, 75009
Ikonisys SA specializes in the design, manufacture, and marketing of medical diagnostic equipment. The company offers cell diagnostic products in the fields of cancer diagnosis, detection of genetic disorders, and fertility testing.
65GF Score

Get the complete analysis for FRA:9W8

Accounts Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€1.37
Price
€3.68
GF Value